Detalles de la búsqueda
1.
Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study.
Value Health
; 27(2): 216-225, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37951538
2.
Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot.
BMC Infect Dis
; 24(1): 137, 2024 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38287234
3.
Recommendations for collection and integration of community-based testing and linkage to care data into national surveillance, monitoring and evaluation systems for HIV, viral hepatitis and sexually transmitted infections: results from the INTEGRATE Joint Action.
BMC Infect Dis
; 21(Suppl 2): 794, 2021 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34517821
4.
Integration of community-based testing data into national HIV surveillance in Poland, Serbia and Slovakia within the framework of INTEGRATE project.
BMC Infect Dis
; 21(Suppl 2): 800, 2021 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34517839
5.
Hepatitis C Screening in Community-Based Voluntary Counselling and Testing Services in Europe: An Observational Study from the COBATEST Network 2014-2018.
J Community Health
; 45(3): 606-614, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31749115
6.
The contribution of HIV point-of-care tests in early HIV diagnosis: community-based HIV testing monitoring in Catalonia, 1995 to 2018.
Euro Surveill
; 25(43)2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33124552
7.
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study.
Int J Drug Policy
; 127: 104394, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38608357
8.
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs.
Int J Drug Policy
; 128: 104468, 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38795465
9.
People engaged in opioid agonist treatment as a counterpublic during the COVID-19 pandemic in Australia: A qualitative study.
Drug Alcohol Rev
; 42(1): 203-212, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36054577
10.
Substance use disorders and COVID-19: reflections on international research and practice changes during the "poly-crisis".
Front Public Health
; 11: 1201967, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37529435
11.
Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study.
Implement Sci
; 18(1): 22, 2023 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37296448
12.
"You'll come in and dose even in a global pandemic": A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic.
Int J Drug Policy
; 114: 103998, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36907071
13.
Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study.
Int J Drug Policy
; 114: 103982, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36863287
14.
Typology of laws restricting access to methadone treatment in the United States: A latent class analysis.
Int J Drug Policy
; 119: 104141, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37540917
15.
Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study.
Open Forum Infect Dis
; 10(11): ofad517, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38023551
16.
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis.
Int J Drug Policy
; 111: 103917, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36542883
17.
Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study.
Int J Drug Policy
; 110: 103876, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36240657
18.
Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study.
Viruses
; 14(11)2022 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36366561
19.
Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatment.
Drug Alcohol Depend
; 235: 109438, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35430521
20.
Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis.
Lancet Gastroenterol Hepatol
; 7(5): 426-445, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35303490